Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2020 | Jul. 30, 2020 | |
Cover [Abstract] | ||
Entity Registrant Name | BARFRESH FOOD GROUP INC. | |
Entity Central Index Key | 0001487197 | |
Document Type | 10-Q | |
Document Period End Date | Jun. 30, 2020 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Entity Reporting Status Current | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business Flag | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 143,643,146 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2020 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) | Jun. 30, 2020 | Dec. 31, 2019 |
Current assets: | ||
Cash | $ 3,029,694 | $ 999,989 |
Restricted cash | 368,582 | 91,385 |
Accounts receivable, net | 405,689 | 284,668 |
Inventory, net | 809,196 | 634,746 |
Prepaid expenses and other current assets | 24,215 | 17,606 |
Total current assets | 4,637,376 | 2,028,394 |
Property, plant and equipment, net of depreciation | 2,161,639 | 2,406,317 |
Operating lease right-of-use assets, net | 176,325 | 203,287 |
Intangible assets, net of amortization | 451,991 | 479,503 |
Deposits | 8,304 | 8,304 |
Total Assets | 7,435,635 | 5,125,805 |
Current liabilities: | ||
Accounts payable | 429,515 | 625,068 |
Accrued expenses | 296,993 | 250,125 |
Accrued payroll | 124,395 | 215,601 |
Accrued vacation | 112,534 | 95,851 |
Accrued interest | 487,978 | |
Lease liability | 58,763 | 56,692 |
Convertible notes, net of discount | 62,066 | 150,742 |
Derivative liabilities | 6,774 | |
Total current liabilities | 1,091,040 | 1,882,057 |
Long term liabilities: | ||
Accrued interest | 117,525 | |
Lease liability | 129,746 | 159,177 |
Note payable | 568,131 | |
Convertible note - related party, net of discount | 193,399 | 1,181,942 |
Convertible note, net of discount | 948,102 | 1,407,877 |
Derivative liabilities | 34,143 | 211,028 |
Total liabilities | 3,082,086 | 4,842,081 |
Commitments and contingencies (Note 6,7,8and 9) | ||
Stockholders' equity: | ||
Preferred stock, $0.000001 par value, 5,000,000 shares authorized, none issued or outstanding | ||
Common stock, $0.000001 par value; 295,000,000 shares authorized; 143,543,146 and 130,341,737 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively | 143 | 130 |
Additional paid in capital | 53,023,114 | 47,030,716 |
Accumulated deficit | (48,669,708) | (46,747,122) |
Total stockholders' equity | 4,353,549 | 283,724 |
Total Liabilities and Stockholders' Equity | $ 7,435,635 | $ 5,125,805 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Jun. 30, 2020 | Dec. 31, 2019 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value | $ 0.000001 | $ 0.000001 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Common stock, par value | $ 0.000001 | $ 0.000001 |
Common stock, shares authorized | 295,000,000 | 295,000,000 |
Common stock, shares issued | 143,543,146 | 130,341,737 |
Common stock, shares outstanding | 143,543,146 | 130,341,737 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Income Statement [Abstract] | ||||
Revenue | $ 506,276 | $ 1,382,665 | $ 1,240,156 | $ 2,217,199 |
Cost of revenue | 389,815 | 512,245 | 718,449 | 899,969 |
Depreciation of Manufacturing Equipment | 1,155 | 19,374 | 9,602 | 31,480 |
Gross profit | 115,306 | 851,046 | 512,105 | 1,285,750 |
Operating expenses: | ||||
General and administrative | 1,084,040 | 1,785,820 | 2,308,465 | 3,789,264 |
Depreciation and Amortization | 153,500 | 155,074 | 303,648 | 357,051 |
Total operating expenses | 1,237,540 | 1,940,894 | 2,612,113 | 4,146,315 |
Operating loss | (1,122,234) | (1,089,848) | (2,100,008) | (2,860,565) |
Other (income)/expenses | ||||
Gain from derivative liability | (6,197) | (798,746) | (157,099) | (392,734) |
Gain from debt extinguishment | (379,200) | |||
Warrant modification | 307,460 | |||
Interest expense | 63,483 | 282,814 | 358,877 | 645,887 |
Total other expense/(income) | 57,286 | (515,932) | (177,422) | 560,613 |
Net (loss) | $ (1,179,520) | $ (573,916) | $ (1,922,586) | $ (3,421,178) |
Per share information - basic and fully diluted: | ||||
Weighted average shares outstanding | 143,498,391 | 128,283,091 | 137,728,422 | 126,480,323 |
Net (loss) per share | $ (0.01) | $ 0 | $ (0.01) | $ (0.03) |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
Jun. 30, 2020 | Jun. 30, 2019 | |
Statement of Cash Flows [Abstract] | ||
Net Cash (used for) Operating Activities | $ (1,930,045) | $ (2,354,225) |
Investing Activities | ||
Purchase of property and equipment | (34,365) | (319,157) |
Purchase of Intangibles | (4,293) | (182) |
Net Cash (used for) Investing Activities | (38,658) | (319,339) |
Financing Activities | ||
Cash received for Warrant Exercises | 1,500,310 | |
Cash received for Stock | 3,825,000 | 2,400,000 |
Proceeds from notes payable | 568,131 | |
Repayment of convertible notes | (90,166) | |
Payments of operating leases | (27,360) | |
Net Cash from Financing Activities | 4,275,605 | 3,900,310 |
Net Change in Cash and Restricted Cash | 2,306,902 | 1,226,746 |
Cash and Restricted Cash, Beginning of Year | 1,091,374 | 1,041,569 |
Cash and Restricted Cash, End of Year | 3,398,276 | 2,268,315 |
Non-Cash Financing and Investing Activities | ||
Property and equipment included in accounts payable | 12,661 | |
Convertible note principal and interest settled through warrant exercise | 384,563 | |
Operating lease right of use asset | 241,555 | |
Executive Deferred Compensation settled through issuance of warrants | 167,892 | |
Net carrying value of convertible notes and accrued interest settled through issuance of stock (debt extinguishment) | 1,770,963 | |
Accrued interest settled through issuance of stock | 379,350 | |
Debt discount warrant and derivative liability | 107,611 | |
Offering and debt issuance costs included in accounts payable | $ 39,208 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2020 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 1. Summary of Significant Accounting Policies Barfresh Food Group Inc., (“we,” “us,” “our,” and the “Company”) was incorporated on February 25, 2010 in the State of Delaware. We are engaged in the manufacturing and distribution of ready to blend beverages, particularly, smoothies, shakes and frappes. The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Basis of Consolidation The consolidated financial statements include the financial statements of the Company and our wholly owned subsidiaries, Barfresh Inc. and Barfresh Corporation Inc. (formerly known as Smoothie, Inc.). All inter-company balances and transactions among the companies have been eliminated upon consolidation. Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates. Concentration of Credit Risk The amount of cash on deposit with financial institutions can be in excess of the $250,000 federally insured limit. However, we believe that cash on deposit that exceeds $250,000 in the financial institutions is financially sound and the risk of loss is minimal. Restricted Cash The Company adopted FASB ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which enhances and clarifies the guidance on the classification and presentation of restricted cash in the statement of cash flows and requires additional disclosures about restricted cash balances. At June 30, 2020 and December 31, 2019, the Company had $368,582 and $91,385, respectively, in restricted cash related to our co-packing agreement with Yarnell Operations, LLC. Fair Value Measurement Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value. Our financial instruments consist of cash, accounts receivable, accounts payable, derivative liabilities, and convertible notes. The carrying value of our financial instruments approximates their fair value, except for the derivative liability in which carrying value is fair value. Accounts Receivable Accounts receivable are typically unsecured. Our credit policy calls for payment generally within 30 days. The credit worthiness of a customer is evaluated prior to a sale. As of June 30, 2020 and December 31, 2019, the Company’s allowance for doubtful accounts was $141,788 and $141,788, respectively. The allowance was estimated based on evaluation of collectability of outstanding accounts receivable. Inventory Inventory consists of raw materials and finished goods and is carried at the lower of cost or net realizable value on a first in first out basis. The Company monitors the remaining useful life of its inventory and establishes a reserve of obsolescence where appropriate. As of June 30, 2020 and December 31, 2019, the Company’s inventory reserve was $31,476 and $100,651, respectively. Intangible Assets Intangible assets are comprised of patents, net of amortization and trademarks. The patent costs are being amortized over the life of the patent, which is twenty years from the date of filing the patent application. In accordance with ASC Topic 350 Intangibles – Goodwill and Other In accordance with ASC 350 legal costs related to trademarks have been capitalized. We have determined that trademarks have an indeterminable life and therefore are not being amortized. Long-Lived Assets and Other Acquired Intangible Assets We evaluate the recoverability of property and equipment and finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of property and equipment and intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value. We have not recorded any impairment charges during the periods presented. Property, Plant, and Equipment Property, plant, and equipment is stated at cost less accumulated depreciation and accumulated impairment loss, if any. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. Leasehold improvements are being amortized over the shorter of the useful life of the asset or the lease term that includes any expected renewal periods that are deemed to be reasonably assured. The estimated useful lives used for financial statement purposes are: Furniture and fixtures: 5 years Manufacturing equipment and customer equipment: 3 years to 7 years Vehicles: 5 years Leases: We determine if an arrangement is a lease upon inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The right to control the use of an asset includes the right to obtain substantially all of the economic benefits of the underlying asset and the right to direct how and for what purpose the asset is used. After adoption of ASU 2016-02 and related standards, operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As a lessee, the Company leases office space. Revenue Recognition In accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods. The Company adopted this standard at the beginning of fiscal year 2018, with no significant impact to its financial position or results of operations, using the modified retrospective method. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods. The Company applies the following five steps: 1) Identify the contract with a customer A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also be supplemented by other agreements that formalize various terms and conditions with customers. 2) Identify the performance obligation in the contract Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the Company, this consists of the delivery of frozen beverages, which provide immediate benefit to the customer. 3) Determine the transaction price The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods and is generally stated on the approved sales order. Variable consideration, which typically includes volume-based rebates or discounts, are estimated utilizing the most likely amount method. 4) Allocate the transaction price to performance obligations in the contract Since our contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated to that single performance obligation. 5) Recognize Revenue when or as the Company satisfies a performance obligation The Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods, which generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or discounts are treated as a reduction of sales at the time the sale is recognized. Shipping and storage costs are treated as fulfillment costs and presented in distribution, selling and administrative costs. The Company evaluated the requirement to disaggregate revenue and concluded that substantially all of its revenue comes from a single product, frozen beverages. Research and Development Expenditures for research activities relating to product development and improvement are charged to general and administrative and are expensed as incurred. We incurred $93,730 and $116,786, in research and development expenses for the three-months ended June 30, 2020 and 2019, respectively. For the six-month periods ended June 30, 2020 and 2019, research and development costs totaled $179,154 and $272,985, respectively. Shipping and Storage Costs Shipping and storage costs are included in general and administrative expenses. For the three-month periods ended June 30, 2020 and 2019, shipping and storage costs totaled $96,425 and $192,628, respectively. For the six-month periods ended June 30, 2020 and 2019, shipping and storage costs totaled $229,533 and $342,274, respectively. Income Taxes The provision for income taxes is determined in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements, uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all of the deferred tax assets will not be recognized. For the three and six-months ended June 30, 2020 and 2019, we did not have any interest and penalties or any unrecognized uncertain tax positions. Derivative Liability The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC Topic 815, “Derivatives and Hedging.” The result of this accounting treatment is that the fair value of any derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as gain/loss from derivative liability. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. We analyzed the derivative financial instruments in accordance with ASC 815. The objective is to provide guidance for determining whether an equity-linked financial instrument is indexed to an entity’s own stock. This determination is needed for a scope exception which would enable a derivative instrument to be accounted for under the accrual method. The classification of a non-derivative instrument that falls within the scope of ASC 815-40-05 “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock” also hinges on whether the instrument is indexed to an entity’s own stock. A non-derivative instrument that is not indexed to an entity’s own stock cannot be classified as equity and must be accounted for as a liability. There is a two-step approach in determining whether an instrument or embedded feature is indexed to an entity’s own stock. First, the instrument’s contingent exercise provisions, if any, must be evaluated, followed by an evaluation of the instrument’s settlement provisions. The Company utilized the fair value standard set forth by the Financial Accounting Standards Board, defined as the amount at which the asset (or liability) could be bought (or incurred) or sold (or settled) in a current transaction between willing parties, that is, other than in a forced or liquidation sale. Debt Extinguishment The Company evaluates its convertible instruments in accordance with ASC 470-50, “Debt Modifications and Extinguishments.” For all extinguishments of debt, ASC 470-50 requires the difference between the reacquisition price (including any premium) and the net carrying amount of the debt being extinguished (including any deferred debt issuance costs) to be recognized as a gain or loss when the debt is extinguished. Accordingly, the Company recorded a net gain $0 and $379,200, respectively, non-cash gain on extinguishment of debt in its statements of operations for the three and six months ended June 30, 2020. Earnings per Share We calculate net loss per share in accordance with ASC Topic 260, Earnings per Share Stock Based Compensation We calculate stock compensation in accordance with ASC Topic 718, Compensation-Stock Based Compensation Recent pronouncements From time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We believe that the impact of recently issued standards that are not yet effective may have an impact on our results of operations and financial position. On October 1, 2019, the FASB issued Accounting Standards Update No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-04) using the prospective approach, which eliminates step two from the goodwill impairment test. Under ASU 2017-04, an entity should recognize an impairment charge for the amount by which the carrying amount of a reporting unit exceeds its fair value up to the amount of goodwill allocated to that reporting unit. This guidance was effective beginning January 1, 2020, with early adoption permitted. The adoption of this new standard did not have a material impact on our consolidated financial statements. |
Inventory
Inventory | 6 Months Ended |
Jun. 30, 2020 | |
Inventory Disclosure [Abstract] | |
Inventory | Note 2. Inventory Inventory consists of the following at June 30, 2020 and December 31, 2019: 2020 2019 Raw materials $ 349,965 $ 286,027 Finished goods, net of reserve 459,231 348,719 Inventory, net $ 809,196 $ 634,746 The Company has recorded a reserve for slow moving and potentially obsolete inventory. The reserve at June 30, 2020 and December 31, 2019 was $31,476 and $100,651, respectively. |
Property Plant and Equipment
Property Plant and Equipment | 6 Months Ended |
Jun. 30, 2020 | |
Property, Plant and Equipment [Abstract] | |
Property Plant and Equipment | Note 3. Property Plant and Equipment Major classes of property and equipment at June 30, 2020 and December 31, 2019: 2020 2019 Furniture and fixtures $ 1,524 $ 1,524 Manufacturing Equipment and customer equipment 3,549,303 3,521,636 Leasehold Improvements 4,886 4,886 Vehicles 29,696 29,696 3,585,409 3,557,742 Less: accumulated depreciation (2,066,200 ) (1,787,967 ) 1,519,209 1,769,775 Equipment not yet placed in service 642,430 636,542 Property and equipment, net of depreciation $ 2,161,639 $ 2,406,317 We recorded depreciation expense related to these assets of $153,500 and $155,074 for the three-months ended June 30, 2020 and 2019, respectively and $303,648 and $357,051 for the six months ended June 30, 2020 and 2019, respectively. Depreciation expense in Cost of Goods Sold was $1,155 and $19,374 for three-months ended June 30, 2020 and 2019 respectively and $9,602 and $31,480 for the six months ended June 30, 2020 and 2019, respectively. |
Intangible Assets
Intangible Assets | 6 Months Ended |
Jun. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets | Note 4. Intangible Assets As of June 30, 2020, intangible assets consist of patent costs of $764,891, trademarks of $112,926 and accumulated amortization of $425,826. As of December 31, 2019, intangible assets consist of patent costs of $764,891, trademarks of $108,632 and accumulated amortization of $394,020. The amounts carried on the balance sheet represent cost to acquire, legal fees and similar costs relating to the patents incurred by the Company. Amortization is calculated through the expiration date of the patents, which is December 2025. The amount charged to amortization was $15,902 and $15,902 for the three-months ended June 30, 2020 and 2019, respectively, and $31,805 and $31,805 for the six months ended June 30, 2020 and 2019, respectively. Estimated future amortization expense related to patents as of June 30, 2020, is as follows: Total Amortization Years ending December 31, 2020 (six months remaining) $ 31,805 2021 63,610 2022 63,610 2023 63,610 2024 63,610 Later years 52,820 $ 339,065 |
Related Parties
Related Parties | 6 Months Ended |
Jun. 30, 2020 | |
Related Party Transactions [Abstract] | |
Related Parties | Note 5. Related Parties As disclosed below in Note 7, members of management and directors invested in the Company’s convertible notes; and in Note 10, members of management and directors have received shares of stock and options in exchange for services. |
Paycheck Protection Program (PP
Paycheck Protection Program (PPP) Loan | 6 Months Ended |
Jun. 30, 2020 | |
Debt Disclosure [Abstract] | |
Paycheck Protection Program (PPP) Loan | Note 6. Paycheck Protection Program (PPP) loan The Company was granted a $568,131 loan under the PPP administered by a Small Business Administration (SBA) approved partner. The loan, which matures in two years, is uncollateralized and is fully guaranteed by the Federal government. The Company is eligible for loan forgiveness of up to 100% of the loan, upon meeting certain requirements. The Company has recorded a note payable and will record the forgiveness upon being legally released from the loan obligation by the SBA. No forgiveness income has been recorded for the quarter ended June 30, 2020. The Company will be required to repay any remaining balance, plus interest accrued at 1 percent, in monthly payments commencing upon notification that the loan will not be forgiven or only partially forgiven. |
Convertible Notes (Related and
Convertible Notes (Related and Unrelated Party) | 6 Months Ended |
Jun. 30, 2020 | |
Debt Disclosure [Abstract] | |
Convertible Notes (Related and Unrelated Party) | Note 7. Convertible Notes (Related and Unrelated Party) On March 20, 2020, we completed a Private Placement offering of $3,825,000 of common stock. In connection with the transaction, the Company offered the Convertible Noteholders of Series CN Note 1 and 2 to participate in the equity offering. A total of $720,000 principal balance of Series CN 1 was converted into common stock [$630,000 from related parties]. The Series CN Note 1 Noteholders were offered bonus interest equivalent to 20% of their outstanding principal which was converted to common stock. For $1,071,000 of the remaining $1,186,167 Series CN Note 1 Noteholders that chose not to participate in the equity offering, the terms of the Series CN Note 1 were amended to increase the interest rate to 15% per annum and to extend the maturity of the outstanding principal balance by 24 months to March 20, 2022. The notes are convertible at any time prior to the maturity into our common stock at a conversion price of $0.50 per share. If the six month price is less than the $0.50 per share, the principal conversion price will be automatically reduced to the $0.50 per share, but in no event less than $0.35 per Share, in which case the Company shall issue to each purchaser, based on such purchaser’s investment, (a) shares in a quantity that equals the difference between the number of Shares issued to such purchaser at closing and the number of Shares that would have been issued to such purchaser at closing at the $0.50 per share and (b) warrants in a quantity that equals fifty percent (50%) of the difference between the number of shares issued to such Purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the $0.50 per share, with an exercise price that equals the sum of $0.10 per share and the 0.50 per share, but in no event less than $0.45 per share. The exercise price per share for the Convertible Note Warrants and the Bonus Warrant issued at closing will automatically adjust as well to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. There were 864,000 O warrants issued to the Series CN Note 1 Noteholders for participating in the common stock offering. On March 20, 2020, 1,082,727 of the original L Warrants related to the Series CN Note 1 Noteholders had their terms modified, whereby the exercise price was reduced from $0.70 to $0.50 per share. In addition, the Series CN Note 1 Noteholders that chose to extend their notes for 24 months were granted 1,071,000 Series P warrants. The fair value of the warrants, ($92,266 in the aggregate which consists of the L and P Warrants), were calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 1 to 3 Volatility 76.74- 98.00 % Risk Free interest rate .15 - .41 % Dividend yield (on common stock) - Based on the relative fair value, we recorded a debt discount of $75,184 related to the issue of P Warrants to CN 1 and CN 2 Noteholders. The modification of the L Warrants resulted in an incremental increase in fair value of $17,082, which was recorded as a debt discount. The convertible notes consist of the following components as of June 30, 2020 and December 31, 2019: June 30, 2020 December 31, 2019 Convertible notes $ 1,181,167 $ 2,704,800 Less: Debt discount (warrant value) (92,266 ) (325,747 ) Less: Debt discount (derivative value) (Note 8) - (638,988 ) Less: Debt discount (issuance costs paid) (6,004 ) (27,000 ) Less: Note repayments/conversion (110,166 ) (803,634 ) Add: Debt discount amortization 13,605 898,940 $ 986,336 $ 1,808,371 On March 20, 2020, a total of $1,128,000 principal balance of Series CN Note 2 was converted into common stock [$560,000 from related parties]. The Noteholders were offered bonus interest equivalent to 20% of their outstanding principal and converted their accrued interest into common stock. For $168,000 of the remaining $235,200 Series CN Note 2 Noteholders that chose not to participate in the equity offering, the terms of the Series CN Note 2 were amended to extend the maturity of the outstanding principal balance by 12 months to November 30, 2021. The notes are convertible at any time prior to the maturity into our common stock at a conversion price of $0.60 per share. There were 1,501,012 O warrants issued to the Series CN Note 2 Noteholders for participating in the common stock offering. The fair value of the modified L warrants, ($4,279 prior to modification, and $6,096 post modification), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 1.71 Volatility 88.02 % Risk Free interest rate 0.37 % Dividend yield (on common stock) - The incremental value of $1,817 was recorded as a debt discount related to the modification of existing L warrants. The convertible notes consist of the following components as of June 30, 2020 and December 31, 2019: June 30, 2020 December 31, 2019 Convertible notes $ 235,200 $ 1,363,200 Less: Debt discount (warrant value) (1,817 ) (212,763 ) Less: Debt discount (derivative value) (Note 8) (13,528 ) (697,186 ) Less: Debt discount (issuance costs paid) (6,004 ) (23,700 ) Add: Debt discount amortization 3,380 508,639 $ 217,231 $ 932,190 The total of the two tables above, net of discount, equals $1,203,567 which is presented on the balance sheet as $62,066 Convertible Note, Net of Discount, Current Liabilities, $193,399 Convertible Note, Related Party, Net of Discount, Long-Term Liabilities and $948,102 Convertible Note, Net of Discount, Long-term Liabilities. The total of $2,740,561 shown in the two tables above at December 31, 2019, are presented in the balance sheet as Long Term Liabilities: Convertible Note – related party net of discount, of $1,181,942, Convertible Note – net of Discount of $1,407,877, and Current Liabilities: Convertible Note – net of Discount $150,742. Future maturity of convertible notes at face value before effect of all discount, are as follow: Total Convertible Notes Years ending December 31, 2020 $ 67,201 2021 168,000 2022 1,071,000 2023 - 2024 - $ 1,306,201 On March 20, 2020 the Company and the Holders of the Series CN Note 1 and Note 2 mutually agreed to amend its terms to change the maturity date to March 20, 2022 and November 30, 2021, respectively. The Company accounted for the modification in accordance with ASC 470-50, Modifications and Extinguishments, which states that for all extinguishments of debt, the difference between the reacquisition price (including any premium) and the net carrying amount of the debt being extinguished (including any deferred debt issuance costs) should be recognized as a gain or loss when the debt is extinguished. Accordingly, the Company recorded a net gain on extinguishment of debt of $379,200 which was comprised of a gain of $437,201, offset by a loss of $58,001. The gain of $437,201 related to the portion of Convertible Notes that were converted to common stock on March 20, 2020. The loss on extinguishment of debt of $58,001 related to the portion of Convertible Notes that were extended by either 24 months for Milestone I, or 12 months for Milestone II. |
Derivative Liabilities
Derivative Liabilities | 6 Months Ended |
Jun. 30, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Liabilities | Note 8. Derivative Liabilities As discussed in Note 7, Convertible Notes, the Company issued Series CN Note acceleration offer convertible notes payable that provide variable conversion provisions. The conversion terms of the convertible notes are variable based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock to be issued is based on the future price of the Company’s common stock, therefore the number of shares of common stock issuable upon conversion of the promissory note is indeterminate. The Convertible Noteholders discussed in Note 7 were provided the option of extending their notes by 24 months or 12 months for the Milestone I March 14, 2020 and Milestone II November 30, 2020 Convertible Note maturities, respectively. Upon completion of the March 20, 2020 offering for common stock and debt restructuring, a balance of $110,167 of Series CN 1 and $168,000 in CN 2 was neither converted, nor extended under the terms of the amendments to both maturities. Consequently, the derivative liabilities referred to above survived outside of debt conversion and modified extension terms and were valued at $6,774 as of June 30, 2020. The fair values of the Company’s derivative liabilities are estimated at the issuance date and are revalued at each subsequent reporting date. The Company recognized a debt discount and related derivative liability of $13,528 at March 20, 2020 related to the Series CN 2 extension. The derivative liability was revalued at June 30, 2020 with a value of $34,143. The fair value of the derivative liabilities for CN Convertible Note 2 of 2 was calculated using the Black-Scholes model using the following assumptions. 30-June-20 31-Dec-19 Expected life 0.42 - 1.68 0.93 Volatility 100.44 -133.12 % 104.89 % Risk Free interest rate 0.16 - 0.18 % 1.58 % Dividend yield (on common stock) - - Reconciliation of the derivative liabilities measured at fair value on a recurring basis with the use of significant unobservable inputs (level 3) from December 31, 2019 to June 30, 2020: December 31, 2019 $ 211,028 Extinguishment change in derivative from conversion (23,100 ) Extinguishment change in derivative from extension (3,440 ) Initial derivative value – March 20, 2020 13,528 Net gain from change in value (157,099 ) For the period ended June 30, 2020 $ 40,917 The following table presents the Company’s fair value hierarchy for applicable assets and liabilities measured at fair value as of December 31, 2019 and June 30, 2020: Level 1 Level 2 Level 3 Total Derivative Liability December 31, 2019 $ - - 211,028 $ 211,028 Level 1 Level 2 Level 3 Total Derivative Liability June 30, 2020 $ - - 40,917 $ 40,917 |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 9. Commitments and Contingencies We lease office space under non-cancelable operating lease which expires on June 30, 2023. Our periodic lease cost and operating cash flow was $19,782 and $13,612 for the three months ended June 30, 2020 and 2019, respectively. Our periodic lease cost and operating cash flow was $39,844 and $50,813 for the six months ended June 30, 2020 and 2019, respectively. As of June 30, 2020, our right of use asset and related liability was $176,325 and $188,509. In determining the present value of our operating lease right-of-use asset and liability, we used a 10% discount rate (which approximates our borrowing rate). The remaining term on the lease is 3 years. The following table presents the future operating lease payment as of June 30, 2020. 2020 (six months remaining) $ 38,152 2021 78,021 2022 80,361 2023 20,238 Total Lease payments 216,772 Less: imputed interest (28,263 ) Total lease liability $ 188,509 |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Jun. 30, 2020 | |
Equity [Abstract] | |
Stockholders' Equity | Note 10. Stockholders’ Equity During the six months ended June 30, 2020, we issued 850,000 options to purchase our common stock to employees and 96,899 options to a Board Member. The exercise price of the options was $0.37 per share, with both cliff and graded vesting over 3 years, and are exercisable for a period of 8 years. The fair value of the options issued ($209,700, in the aggregate) was calculated using the Black-Sholes option pricing model, based on the criteria shown below. Expected life (in years) 5.5 to 8 Volatility (based on a comparable company) 73.36%-75.82 % Risk Free interest rate 0.30%-1.61 % Dividend yield (on common stock) - The shares of our common stock were valued at the trading price on the date of grant, $0.38 per share For the six months ended June 30, 2020, 625,423 options expired or were cancelled. During the first quarter of 2020, the Company settled certain Executive Deferred Compensation payments with the issuance of 1,573,988 warrants. The fair value of the warrants totaled $251,837. The total executive Deferred Compensation that was settled with the issuance of the warrants was $167,892. The difference between the fair value of the warrants and the Executive Deferred Compensation settled of $83,945 was recorded as stock-based compensation during the six months ended June 30, 2020. The total amount of equity-based compensation included in additional paid in capital was $55,812 and $134,607 for the three-months ended June 30, 2020 and 2019, respectively. The total amount of equity-based compensation included in additional paid in capital was $194,524 and $271,548 for the six-months ended June 30, 2020 and 2019, respectively. The following is a summary of outstanding stock options issued to employees and directors as of June 30, 2020: Number Exercise Average Aggregate Outstanding January 1, 2020 7,197,024 .40 - .87 4.55 - Issued 946,899 .37 7.77 - Cancelled/Expired (625,423 ) Outstanding June 30, 2020 7,575,256 .37 - .87 4.38 - Exercisable, June 30, 2020 3,944,901 .40 - .87 3.32 - The following is Changes in Stockholders’ Equity as of June 30, 2019 and June 30, 2020: Additional Common Stock paid in Accumulated Shares Amount Capital (Deficit) Total Balance January 1, 2019 122,770,960 $ 123 $ 41,118,649 $ (41,153,820 ) $ (35,048 ) Exercise of warrants 3,141,454 3 1,884,869 1,884,872 Issuance of stock for services 173,406 - 181,039 - 181,040 Equity based compensation - - 271,548 - 271,548 Warrants issued to Management - - 758,754 - 758,754 Issuance of stock for capital raise 4,000,000 4 2,399,996 - 2,400,000 Warrant modification - - 307,460 - 307,460 Net (loss) for the year - - - (3,421,178 ) (3,421,178 ) Balance June 30, 2019 130,085,820 $ 130 $ 46,922,315 $ (44,574,998 ) $ 2,347,447 Additional Common Stock paid in Accumulated Shares Amount Capital (Deficit) Total Balance January 1, 2020 130,341,737 $ 130 $ 47,030,716 $ (46,747,122 ) $ 283,724 Issuance of stock for capital raise, net of offering costs of $27,200 7,650,000 8 3,797,792 - 3,797,800 Conversion of debt 4,770,030 5 1,333,757 - 1,333,762 Interest paid in shares 632,251 - 379,350 - 379,350 Issuance of stock for services 27,601 - 25,000 - 25,000 Equity based compensation - - 194,524 - 194,524 Warrants issued to management - - 167,892 - 167,892 Warrant Modification - - 18,899 - 18,899 Warrant issued for note extension - - 75,184 - 75,184 Restricted stock issuance 121,527 - - - - Net (loss) for the year - - - (1,922,586 ) (1,922,586 ) Balance June 30, 2020 143,543,146 $ 143 $ 53,023,114 $ (48,669,708 ) $ 4,353,549 On March 20, 2020, the Company completed additional funding, including a Private Placement Offering for common shares priced at $0.50 per share (subject to adjustment) in the amount of $3.825 million and the issuance of 7,650,000 shares. The $3.825 million was received and collected in April 2020. The investors of this Private Placement Offering will be granted O warrants to be eligible to purchase an additional 0.50 shares for every share issued to each purchaser, exercisable for a period of 3 years at an exercise price of $0.60 per share (subject to adjustment). If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the “Six Month Price”) exceeds or equals $0.50 per share (the “Target Price”), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $0.35 per share, in which case the Company shall issue to each investor, pro-rata based on such investor’s investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for a number of shares of common stock equal to 50% of the difference between the number of shares issued to such investor at closing and the number of shares that would have been issued to such investor at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no eventless than $0.45 per share. The exercise price per share for each warrant will automatically adjust to the sum of $0.10 per share and the Six-Month Price, but in no event less than $0.45 per share |
Outstanding Warrants
Outstanding Warrants | 6 Months Ended |
Jun. 30, 2020 | |
Warrants and Rights Note Disclosure [Abstract] | |
Outstanding Warrants | Note 11. Outstanding Warrants The following is a summary of all outstanding warrants as of June 30, 2020: Number of price remaining term in years intrinsic value at date of grant Warrants issued in connection with private placements of common stock 19,048,606 $ 0.53 - $1.00 1.71 $ - Warrants issued in connection with private placement of notes 1,355,000 $ 1.00 .50 $ - Warrants issued in connection with convertible note 3,006,501 $ 0.70 .61 $ - Warrants issued in connection with settlement of deferred compensation 3,169,599 $ 0.27 - 0.70 4.25 $ - |
Income Taxes
Income Taxes | 6 Months Ended |
Jun. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 12. Income Taxes The provision for income taxes is determined in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all of the deferred tax assets will not be recognized. Accordingly, at this time the Company has placed a valuation allowance on all tax assets. As of June 30, 2020, the estimated effective tax rate for the year will be zero. There are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from 2009 through the current period. Our policy is to account for income tax related interest and penalties in income tax expense in the statement of operations. There have been no income tax related interest or penalties assessed or recorded. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This pronouncement also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. For the three and six-month periods ended June 30, 2020 and 2019, we did not have any interest and penalties associated with tax positions. As of June 30, 2020 and December 31, 2019, we did not have any significant unrecognized uncertain tax positions. |
Liquidity
Liquidity | 6 Months Ended |
Jun. 30, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Liquidity | Note 13. Liquidity During the six months ended June 30, 2020, we used cash for operations of $1,930,045 and purchased equipment for $34,365. We sold common stock in the amount of $3,825,000 and converted $2,394,763 of principal and interest from our Convertible Notes into equity. During the six months ended June 30, 2019, we used $2,354,225 of cash for operations and purchased equipment for $319,157. We raised cash of $2,400,000 from the issuance of common stock and we raised cash from the exercise of warrants in the amount of $1,500,310. We have a history of operating losses and negative cash flow. As our operations grow, we expect to experience significant increases in our working capital requirements. Management has evaluated these conditions and concluded substantial doubt was mitigated due to the Company selling common stock as well as restructuring debt. However, the Company cannot predict, with certainty, the outcome of its actions to preserve liquidity, including the accuracy of its financial forecast, the ability to sustain the current trend of cost cutting, the ability to raise additional capital or to extend the maturity date of the debt that is maturing in March of 2022. As of June 30, 2020, we had $3,398,276 of cash and restricted cash on the balance sheet. We have continued to significantly reduce core operating expenses, reducing total General and Administrative Expense in the first six months of 2020 by $1,480,799, or 39%, as compared with the first six months of 2019. The Company’s forecast for the next twelve months reflects a continuation of the improvement in cash flow from operations as the Company continues to reduce operating expenses and increase contracts with school locations, and military bases, and anticipates the roll-out of a new product launch with the Twist & Go 8oz bottles. The Company has implemented cost reduction measures which will reduce cash expenses over the next twelve months, which includes reduced headcount. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2020 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 14. Subsequent Events The impact of COVID-19 on the Company is evolving rapidly with events unfolding on a daily and weekly basis. The direct impact to our operations took affect at the close of the first quarter ended March 31, 2020. Specifically, our business has been impacted by dining bans targeted at restaurants to reduce the size of public gatherings. Restaurant chains have closed operations and furloughed employees which precludes our single serve products from being served at those establishments. Many school districts closed regular attendance during the 2019-2020 school year and are now debating whether to resume in person instruction for the 2020-2021 school year. This directly impacts the sales of our Bulk Product into that sales channel. Our headquarters is located in Los Angeles, California, one of the hardest affected states. We have not experienced a disruption in the supply chain for the manufacturing of our products. The Company applied for and obtained a Small Business Administration loan under the Paycheck Protection Program [PPP] of the CARES Act for approximately $568,000. On June 5, 2020, the President signed a bill which extended the period of loan forgiveness for PPP loans from 8 to 24 weeks, which we believe will enable the loan to be completely forgiven. While many states have commenced the process of reopening various types of businesses, the path to recovering normal activity volumes is uncertain. Three of the largest states [California, Florida and Texas] have experienced a resurgence of both new cases and fatalities. Consequently, the developments surrounding COVID-19 remain fluid and will require the Company to continue to monitor news headlines from government and health officials, as well as, the business community. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jun. 30, 2020 | |
Accounting Policies [Abstract] | |
Basis of Consolidation | Basis of Consolidation The consolidated financial statements include the financial statements of the Company and our wholly owned subsidiaries, Barfresh Inc. and Barfresh Corporation Inc. (formerly known as Smoothie, Inc.). All inter-company balances and transactions among the companies have been eliminated upon consolidation. |
Use of Estimates | Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates. |
Concentration of Credit Risk | Concentration of Credit Risk The amount of cash on deposit with financial institutions can be in excess of the $250,000 federally insured limit. However, we believe that cash on deposit that exceeds $250,000 in the financial institutions is financially sound and the risk of loss is minimal. |
Restricted Cash | Restricted Cash The Company adopted FASB ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which enhances and clarifies the guidance on the classification and presentation of restricted cash in the statement of cash flows and requires additional disclosures about restricted cash balances. At June 30, 2020 and December 31, 2019, the Company had $368,582 and $91,385, respectively, in restricted cash related to our co-packing agreement with Yarnell Operations, LLC. |
Fair Value Measurement | Fair Value Measurement Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value. Our financial instruments consist of cash, accounts receivable, accounts payable, derivative liabilities, and convertible notes. The carrying value of our financial instruments approximates their fair value, except for the derivative liability in which carrying value is fair value. |
Accounts Receivable | Accounts Receivable Accounts receivable are typically unsecured. Our credit policy calls for payment generally within 30 days. The credit worthiness of a customer is evaluated prior to a sale. As of June 30, 2020 and December 31, 2019, the Company’s allowance for doubtful accounts was $141,788 and $141,788, respectively. The allowance was estimated based on evaluation of collectability of outstanding accounts receivable. |
Inventory | Inventory Inventory consists of raw materials and finished goods and is carried at the lower of cost or net realizable value on a first in first out basis. The Company monitors the remaining useful life of its inventory and establishes a reserve of obsolescence where appropriate. As of June 30, 2020 and December 31, 2019, the Company’s inventory reserve was $31,476 and $100,651, respectively. |
Intangible Assets | Intangible Assets Intangible assets are comprised of patents, net of amortization and trademarks. The patent costs are being amortized over the life of the patent, which is twenty years from the date of filing the patent application. In accordance with ASC Topic 350 Intangibles – Goodwill and Other In accordance with ASC 350 legal costs related to trademarks have been capitalized. We have determined that trademarks have an indeterminable life and therefore are not being amortized. |
Long-Lived Assets and Other Acquired Intangible Assets | Long-Lived Assets and Other Acquired Intangible Assets We evaluate the recoverability of property and equipment and finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of property and equipment and intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value. We have not recorded any impairment charges during the periods presented. |
Property, Plant, and Equipment | Property, plant, and equipment is stated at cost less accumulated depreciation and accumulated impairment loss, if any. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. Leasehold improvements are being amortized over the shorter of the useful life of the asset or the lease term that includes any expected renewal periods that are deemed to be reasonably assured. The estimated useful lives used for financial statement purposes are: Furniture and fixtures: 5 years Manufacturing equipment and customer equipment: 3 years to 7 years Vehicles: 5 years |
Leases | Leases: We determine if an arrangement is a lease upon inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The right to control the use of an asset includes the right to obtain substantially all of the economic benefits of the underlying asset and the right to direct how and for what purpose the asset is used. After adoption of ASU 2016-02 and related standards, operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As a lessee, the Company leases office space. |
Revenue Recognition | Revenue Recognition In accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods. The Company adopted this standard at the beginning of fiscal year 2018, with no significant impact to its financial position or results of operations, using the modified retrospective method. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods. The Company applies the following five steps: 1) Identify the contract with a customer A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also be supplemented by other agreements that formalize various terms and conditions with customers. 2) Identify the performance obligation in the contract Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the Company, this consists of the delivery of frozen beverages, which provide immediate benefit to the customer. 3) Determine the transaction price The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods and is generally stated on the approved sales order. Variable consideration, which typically includes volume-based rebates or discounts, are estimated utilizing the most likely amount method. 4) Allocate the transaction price to performance obligations in the contract Since our contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated to that single performance obligation. 5) Recognize Revenue when or as the Company satisfies a performance obligation The Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods, which generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or discounts are treated as a reduction of sales at the time the sale is recognized. Shipping and storage costs are treated as fulfillment costs and presented in distribution, selling and administrative costs. The Company evaluated the requirement to disaggregate revenue and concluded that substantially all of its revenue comes from a single product, frozen beverages. |
Research and Development | Research and Development Expenditures for research activities relating to product development and improvement are charged to general and administrative and are expensed as incurred. We incurred $93,730 and $116,786, in research and development expenses for the three-months ended June 30, 2020 and 2019, respectively. For the six-month periods ended June 30, 2020 and 2019, research and development costs totaled $179,154 and $272,985, respectively. |
Shipping and Storage Costs | Shipping and Storage Costs Shipping and storage costs are included in general and administrative expenses. For the three-month periods ended June 30, 2020 and 2019, shipping and storage costs totaled $96,425 and $192,628, respectively. For the six-month periods ended June 30, 2020 and 2019, shipping and storage costs totaled $229,533 and $342,274, respectively. |
Income Taxes | Income Taxes The provision for income taxes is determined in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements, uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all of the deferred tax assets will not be recognized. For the three and six-months ended June 30, 2020 and 2019, we did not have any interest and penalties or any unrecognized uncertain tax positions. |
Derivative Liability | Derivative Liability The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC Topic 815, “Derivatives and Hedging.” The result of this accounting treatment is that the fair value of any derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as gain/loss from derivative liability. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. We analyzed the derivative financial instruments in accordance with ASC 815. The objective is to provide guidance for determining whether an equity-linked financial instrument is indexed to an entity’s own stock. This determination is needed for a scope exception which would enable a derivative instrument to be accounted for under the accrual method. The classification of a non-derivative instrument that falls within the scope of ASC 815-40-05 “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock” also hinges on whether the instrument is indexed to an entity’s own stock. A non-derivative instrument that is not indexed to an entity’s own stock cannot be classified as equity and must be accounted for as a liability. There is a two-step approach in determining whether an instrument or embedded feature is indexed to an entity’s own stock. First, the instrument’s contingent exercise provisions, if any, must be evaluated, followed by an evaluation of the instrument’s settlement provisions. The Company utilized the fair value standard set forth by the Financial Accounting Standards Board, defined as the amount at which the asset (or liability) could be bought (or incurred) or sold (or settled) in a current transaction between willing parties, that is, other than in a forced or liquidation sale. |
Debt Extinguishment | Debt Extinguishment The Company evaluates its convertible instruments in accordance with ASC 470-50, “Debt Modifications and Extinguishments.” For all extinguishments of debt, ASC 470-50 requires the difference between the reacquisition price (including any premium) and the net carrying amount of the debt being extinguished (including any deferred debt issuance costs) to be recognized as a gain or loss when the debt is extinguished. Accordingly, the Company recorded a net gain $0 and $379,200, respectively, non-cash gain on extinguishment of debt in its statements of operations for the three and six months ended June 30, 2020. |
Earnings Per Share | Earnings per Share We calculate net loss per share in accordance with ASC Topic 260, Earnings per Share |
Stock Based Compensation | Stock Based Compensation We calculate stock compensation in accordance with ASC Topic 718, Compensation-Stock Based Compensation |
Recent Pronouncements | Recent pronouncements From time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We believe that the impact of recently issued standards that are not yet effective may have an impact on our results of operations and financial position. On October 1, 2019, the FASB issued Accounting Standards Update No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-04) using the prospective approach, which eliminates step two from the goodwill impairment test. Under ASU 2017-04, an entity should recognize an impairment charge for the amount by which the carrying amount of a reporting unit exceeds its fair value up to the amount of goodwill allocated to that reporting unit. This guidance was effective beginning January 1, 2020, with early adoption permitted. The adoption of this new standard did not have a material impact on our consolidated financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Accounting Policies [Abstract] | |
Summary of Estimated Useful Lives of Assets | The estimated useful lives used for financial statement purposes are: Furniture and fixtures: 5 years Manufacturing equipment and customer equipment: 3 years to 7 years Vehicles: 5 years |
Inventory (Tables)
Inventory (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | Inventory consists of the following at June 30, 2020 and December 31, 2019: 2020 2019 Raw materials $ 349,965 $ 286,027 Finished goods, net of reserve 459,231 348,719 Inventory, net $ 809,196 $ 634,746 |
Property Plant and Equipment (T
Property Plant and Equipment (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Major Classes of Property and Equipment | Major classes of property and equipment at June 30, 2020 and December 31, 2019: 2020 2019 Furniture and fixtures $ 1,524 $ 1,524 Manufacturing Equipment and customer equipment 3,549,303 3,521,636 Leasehold Improvements 4,886 4,886 Vehicles 29,696 29,696 3,585,409 3,557,742 Less: accumulated depreciation (2,066,200 ) (1,787,967 ) 1,519,209 1,769,775 Equipment not yet placed in service 642,430 636,542 Property and equipment, net of depreciation $ 2,161,639 $ 2,406,317 |
Intangible Assets (Tables)
Intangible Assets (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Estimated Future Amortization Expense Related to Intangible Property | Estimated future amortization expense related to patents as of June 30, 2020, is as follows: Total Amortization Years ending December 31, 2020 (six months remaining) $ 31,805 2021 63,610 2022 63,610 2023 63,610 2024 63,610 Later years 52,820 $ 339,065 |
Convertible Notes (Related an_2
Convertible Notes (Related and Unrelated Party) (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Debt Disclosure [Abstract] | |
Schedule of Fair Value Assumptions Used | The fair value of the warrants, ($92,266 in the aggregate which consists of the L and P Warrants), were calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 1 to 3 Volatility 76.74- 98.00 % Risk Free interest rate .15 - .41 % Dividend yield (on common stock) - The fair value of the modified L warrants, ($4,279 prior to modification, and $6,096 post modification), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 1.71 Volatility 88.02 % Risk Free interest rate 0.37 % Dividend yield (on common stock) - |
Schedule of Convertible Notes | The convertible notes consist of the following components as of June 30, 2020 and December 31, 2019: June 30, 2020 December 31, 2019 Convertible notes $ 1,181,167 $ 2,704,800 Less: Debt discount (warrant value) (92,266 ) (325,747 ) Less: Debt discount (derivative value) (Note 8) - (638,988 ) Less: Debt discount (issuance costs paid) (6,004 ) (27,000 ) Less: Note repayments/conversion (110,166 ) (803,634 ) Add: Debt discount amortization 13,605 898,940 $ 986,336 $ 1,808,371 The convertible notes consist of the following components as of June 30, 2020 and December 31, 2019: June 30, 2020 December 31, 2019 Convertible notes $ 235,200 $ 1,363,200 Less: Debt discount (warrant value) (1,817 ) (212,763 ) Less: Debt discount (derivative value) (Note 8) (13,528 ) (697,186 ) Less: Debt discount (issuance costs paid) (6,004 ) (23,700 ) Add: Debt discount amortization 3,380 508,639 $ 217,231 $ 932,190 |
Schedule of Future Maturities of Convertible Notes | Future maturity of convertible notes at face value before effect of all discount, are as follow: Total Convertible Notes Years ending December 31, 2020 $ 67,201 2021 168,000 2022 1,071,000 2023 - 2024 - $ 1,306,201 |
Derivative Liabilities (Tables)
Derivative Liabilities (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Fair Value of the Derivative Liability | The fair value of the derivative liabilities for CN Convertible Note 2 of 2 was calculated using the Black-Scholes model using the following assumptions. 30-June-20 31-Dec-19 Expected life 0.42 - 1.68 0.93 Volatility 100.44 -133.12 % 104.89 % Risk Free interest rate 0.16 - 0.18 % 1.58 % Dividend yield (on common stock) - - |
Schedule of Derivative Liability Measured at Fair Value on a Recurring Basis | Reconciliation of the derivative liabilities measured at fair value on a recurring basis with the use of significant unobservable inputs (level 3) from December 31, 2019 to June 30, 2020: December 31, 2019 $ 211,028 Extinguishment change in derivative from conversion (23,100 ) Extinguishment change in derivative from extension (3,440 ) Initial derivative value – March 20, 2020 13,528 Net gain from change in value (157,099 ) For the period ended June 30, 2020 $ 40,917 |
Schedule of Fair Value Hierarchy of Assets and Liabilities | The following table presents the Company’s fair value hierarchy for applicable assets and liabilities measured at fair value as of December 31, 2019 and June 30, 2020: Level 1 Level 2 Level 3 Total Derivative Liability December 31, 2019 $ - - 211,028 $ 211,028 Level 1 Level 2 Level 3 Total Derivative Liability June 30, 2020 $ - - 40,917 $ 40,917 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Estimate Future Maturities of Lease Liabilities | The following table presents the future operating lease payment as of June 30, 2020. 2020 (six months remaining) $ 38,152 2021 78,021 2022 80,361 2023 20,238 Total Lease payments 216,772 Less: imputed interest (28,263 ) Total lease liability $ 188,509 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Equity [Abstract] | |
Summary of Fair Value of Options Using Black-Sholes Option Pricing Model | The fair value of the options issued ($209,700, in the aggregate) was calculated using the Black-Sholes option pricing model, based on the criteria shown below. Expected life (in years) 5.5 to 8 Volatility (based on a comparable company) 73.36%-75.82 % Risk Free interest rate 0.30%-1.61 % Dividend yield (on common stock) - |
Summary of Outstanding Stock Options Issued to Employees and Directors | The following is a summary of outstanding stock options issued to employees and directors as of June 30, 2020: Number Exercise Average Aggregate Outstanding January 1, 2020 7,197,024 .40 - .87 4.55 - Issued 946,899 .37 7.77 - Cancelled/Expired (625,423 ) Outstanding June 30, 2020 7,575,256 .37 - .87 4.38 - Exercisable, June 30, 2020 3,944,901 .40 - .87 3.32 - |
Schedule of Changes in Stockholders' Equity | The following is Changes in Stockholders’ Equity as of June 30, 2019 and June 30, 2020: Additional Common Stock paid in Accumulated Shares Amount Capital (Deficit) Total Balance January 1, 2019 122,770,960 $ 123 $ 41,118,649 $ (41,153,820 ) $ (35,048 ) Exercise of warrants 3,141,454 3 1,884,869 1,884,872 Issuance of stock for services 173,406 - 181,039 - 181,040 Equity based compensation - - 271,548 - 271,548 Warrants issued to Management - - 758,754 - 758,754 Issuance of stock for capital raise 4,000,000 4 2,399,996 - 2,400,000 Warrant modification - - 307,460 - 307,460 Net (loss) for the year - - - (3,421,178 ) (3,421,178 ) Balance June 30, 2019 130,085,820 $ 130 $ 46,922,315 $ (44,574,998 ) $ 2,347,447 Additional Common Stock paid in Accumulated Shares Amount Capital (Deficit) Total Balance January 1, 2020 130,341,737 $ 130 $ 47,030,716 $ (46,747,122 ) $ 283,724 Issuance of stock for capital raise, net of offering costs of $27,200 7,650,000 8 3,797,792 - 3,797,800 Conversion of debt 4,770,030 5 1,333,757 - 1,333,762 Interest paid in shares 632,251 - 379,350 - 379,350 Issuance of stock for services 27,601 - 25,000 - 25,000 Equity based compensation - - 194,524 - 194,524 Warrants issued to management - - 167,892 - 167,892 Warrant Modification - - 18,899 - 18,899 Warrant issued for note extension - - 75,184 - 75,184 Restricted stock issuance 121,527 - - - - Net (loss) for the year - - - (1,922,586 ) (1,922,586 ) Balance June 30, 2020 143,543,146 $ 143 $ 53,023,114 $ (48,669,708 ) $ 4,353,549 |
Outstanding Warrants (Tables)
Outstanding Warrants (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Warrants and Rights Note Disclosure [Abstract] | |
Summary of Outstanding Warrants | The following is a summary of all outstanding warrants as of June 30, 2020: Number of price remaining term in years intrinsic value at date of grant Warrants issued in connection with private placements of common stock 19,048,606 $ 0.53 - $1.00 1.71 $ - Warrants issued in connection with private placement of notes 1,355,000 $ 1.00 .50 $ - Warrants issued in connection with convertible note 3,006,501 $ 0.70 .61 $ - Warrants issued in connection with settlement of deferred compensation 3,169,599 $ 0.27 - 0.70 4.25 $ - |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details Narrative) - USD ($) | Mar. 20, 2020 | Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Dec. 31, 2019 |
Cash federally insured limit value | $ 250,000 | $ 250,000 | ||||
Cash on deposit exceeds | 250,000 | 250,000 | ||||
Allowance for doubtful accounts receivable | 141,788 | 141,788 | $ 141,788 | |||
Inventory reserve | 31,476 | 31,476 | 100,651 | |||
Research and development expenses | 93,730 | $ 116,786 | 179,154 | $ 272,985 | ||
Shipping and storage costs | 96,425 | 192,628 | $ 229,533 | 342,274 | ||
Percentage of tax benefits likelihood being realized upon ultimate settlement | Greater than 50% | |||||
Unrecognized uncertain tax positions interest and penalties | ||||||
Gain on extinguishment of debt | $ (379,200) | $ (379,200) | ||||
Patents [Member] | ||||||
Intangible assets useful life | 20 years | |||||
Co-packing Agreement [Member] | Yarnell Operations, LLC [Member] | ||||||
Restricted cash | $ 368,582 | $ 368,582 | $ 91,385 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Assets (Details) | 6 Months Ended |
Jun. 30, 2020 | |
Furniture and Fixtures [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives | 5 years |
Manufacturing Equipment and Customer Equipment [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives | 3 years |
Manufacturing Equipment and Customer Equipment [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives | 7 years |
Vehicles [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives | 5 years |
Inventory (Details Narrative)
Inventory (Details Narrative) - USD ($) | Jun. 30, 2020 | Dec. 31, 2019 |
Inventory Disclosure [Abstract] | ||
Inventory reserve | $ 31,476 | $ 100,651 |
Inventory - Schedule of Invento
Inventory - Schedule of Inventory (Details) - USD ($) | Jun. 30, 2020 | Dec. 31, 2019 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 349,965 | $ 286,027 |
Finished goods, net of reserve | 459,231 | 348,719 |
Inventory, net | $ 809,196 | $ 634,746 |
Property Plant and Equipment (D
Property Plant and Equipment (Details Narrative) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation expense | $ 153,500 | $ 155,074 | $ 303,648 | $ 357,051 |
Depreciation expense in Cost of Goods Sold | $ 1,155 | $ 19,374 | $ 9,602 | $ 31,480 |
Property Plant and Equipment -
Property Plant and Equipment - Schedule of Major Classes of Property and Equipment (Details) - USD ($) | Jun. 30, 2020 | Dec. 31, 2019 |
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 3,585,409 | $ 3,557,742 |
Less: accumulated depreciation | (2,066,200) | (1,787,967) |
Property and equipment | 1,519,209 | 1,769,775 |
Equipment not yet placed in service | 642,430 | 636,542 |
Property and equipment, net of depreciation | 2,161,639 | 2,406,317 |
Furniture and Fixtures [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 1,524 | 1,524 |
Manufacturing Equipment and Customer Equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 3,549,303 | 3,521,636 |
Leasehold Improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 4,886 | 4,886 |
Vehicles [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 29,696 | $ 29,696 |
Intangible Assets (Details Narr
Intangible Assets (Details Narrative) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Dec. 31, 2019 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||||
Patent costs | $ 764,891 | $ 764,891 | $ 764,891 | ||
Trademarks costs | 112,926 | 112,926 | 108,632 | ||
Accumulated amortization on patents and trademarks | 425,826 | $ 425,826 | $ 394,020 | ||
Expiration date of patents | Dec. 31, 2025 | ||||
Amortization of intangible assets | $ 15,902 | $ 15,902 | $ 31,805 | $ 31,805 |
Intangible Assets - Schedule of
Intangible Assets - Schedule of Estimated Future Amortization Expense Related to Intangible Property (Details) | Jun. 30, 2020USD ($) |
Goodwill and Intangible Assets Disclosure [Abstract] | |
2020 (six months remaining) | $ 31,805 |
2021 | 63,610 |
2022 | 63,610 |
2023 | 63,610 |
2024 | 63,610 |
Later years | 52,820 |
Intangible asset, net of amortization | $ 339,065 |
Paycheck Protection Program (_2
Paycheck Protection Program (PPP) Loan (Details Narrative) - USD ($) | 6 Months Ended | |
Jun. 30, 2020 | Jun. 30, 2019 | |
Proceeds from notes payable | $ 568,131 | |
Paycheck Protection Program [Member] | ||
Proceeds from notes payable | $ 568,131 | |
Loan forgiven Description | The Company has recorded a note payable and will record the forgiveness upon being legally released from the loan obligation by the SBA. No forgiveness income has been recorded for the quarter ended June 30, 2020. The Company will be required to repay any remaining balance, plus interest accrued at 1 percent, in monthly payments commencing upon notification that the loan will not be forgiven or only partially forgiven. | |
Paycheck Protection Program [Member] | Maximum [Member] | ||
Eligible loan forgiveness percentage | 100.00% |
Convertible Notes (Related an_3
Convertible Notes (Related and Unrelated Party) (Details Narrative) - USD ($) | Mar. 20, 2020 | Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Dec. 31, 2019 |
Convertible notes | $ 1,203,567 | $ 1,203,567 | $ 2,740,561 | |||
Debt maturity date | Mar. 31, 2022 | |||||
Debt conversion, description | If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the "Six Month Price") exceeds or equals $0.50 per share (the "Target Price"), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $0.35 per share, in which case the Company shall issue to each investor, pro-rata based on such investor's investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for a number of shares of common stock equal to 50% of the difference between the number of shares issued to such investor at closing and the number of shares that would have been issued to such investor at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no eventless than $0.45 per share. The exercise price per share for each warrant will automatically adjust to the sum of $0.10 per share and the Six-Month Price, but in no event less than $0.45 per share | |||||
Fair value of warrants | $ 307,460 | |||||
Convertible note, net of discount | 62,066 | 62,066 | 150,742 | |||
Convertible note related party, non-current | 193,399 | 193,399 | 1,181,942 | |||
Convertible note non-current | 948,102 | 948,102 | $ 1,407,877 | |||
Extinguishment of debt | $ 379,200 | $ 379,200 | ||||
Gain on extinguishment of debt | 437,201 | |||||
Loss on extinguishment of debt | $ 58,001 | |||||
Conversion description | The gain of $437,201 related to the portion of Convertible Notes that were converted to common stock on March 20, 2020. The loss on extinguishment of debt of $58,001 related to the portion of Convertible Notes that were extended by either 24 months for Milestone I, or 12 months for Milestone II. | |||||
Series CN Convertible Notes 1 [Member] | ||||||
Principal balance converted into common stock | $ 720,000 | |||||
Due from related parties | $ 630,000 | |||||
Debt instrument conversion of common stock percentage | 20.00% | |||||
Convertible notes | $ 1,071,000 | |||||
Remaining convertible notes | $ 1,186,167 | |||||
Debt interest rate | 15.00% | |||||
Debt maturity date | Mar. 20, 2022 | |||||
Debt conversion, description | The notes are convertible at any time prior to the maturity into our common stock at a conversion price of $0.50 per share. If the six month price is less than the $0.50 per share, the principal conversion price will be automatically reduced to the $0.50 per share, but in no event less than $0.35 per Share, in which case the Company shall issue to each purchaser, based on such purchaser's investment, (a) shares in a quantity that equals the difference between the number of Shares issued to such purchaser at closing and the number of Shares that would have been issued to such purchaser at closing at the $0.50 per share and (b) warrants in a quantity that equals fifty percent (50%) of the difference between the number of shares issued to such Purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the $0.50 per share, with an exercise price that equals the sum of $0.10 per share and the 0.50 per share, but in no event less than $0.45 per share. The exercise price per share for the Convertible Note Warrants and the Bonus Warrant issued at closing will automatically adjust as well to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. | |||||
Debt conversion price | $ 0.50 | |||||
Closing price of the common stock, percentage | 50.00% | |||||
Series CN Convertible Notes 1 [Member] | O Warrants [Member] | ||||||
Warrant issued | 864,000 | |||||
Series CN Convertible Notes 1 [Member] | L Warrants [Member] | ||||||
Warrant issued | 1,082,727 | |||||
Series CN Convertible Notes 1 [Member] | L Warrants [Member] | Maximum [Member] | ||||||
Warrant exercise price | $ 0.70 | |||||
Series CN Convertible Notes 1 [Member] | L Warrants [Member] | Minimum [Member] | ||||||
Warrant exercise price | $ 0.50 | |||||
Series CN Convertible Notes 1 [Member] | P Warrants [Member] | ||||||
Warrant granted | 1,071,000 | |||||
Series CN Convertible Notes 1 [Member] | L and P Warrants [Member] | ||||||
Fair value of warrants | $ 92,266 | |||||
Series CN Note 1 and 2 [Member] | P Warrants [Member] | ||||||
Fair value of warrants | 17,082 | |||||
Debt discount | 75,184 | |||||
Series CN Convertible Notes 2 [Member] | ||||||
Principal balance converted into common stock | 1,128,000 | |||||
Due from related parties | $ 560,000 | |||||
Debt instrument conversion of common stock percentage | 20.00% | |||||
Convertible notes | $ 168,000 | |||||
Remaining convertible notes | $ 235,200 | |||||
Debt interest rate | 60.00% | |||||
Debt maturity date | Nov. 30, 2021 | |||||
Series CN Convertible Notes 2 [Member] | O Warrants [Member] | ||||||
Warrant issued | 1,501,012 | |||||
Series CN Convertible Notes 2 [Member] | L Warrants [Member] | ||||||
Debt discount | $ 1,817 | |||||
Series CN Convertible Notes 2 [Member] | L Warrants [Member] | Pre Modification [Member] | ||||||
Fair value of warrants | 4,279 | |||||
Series CN Convertible Notes 2 [Member] | L Warrants [Member] | Post Modification [Member] | ||||||
Fair value of warrants | 6,096 | |||||
Private Placement Offering [Member] | ||||||
Proceeds from private placement | $ 3,825,000 |
Convertible Notes (Related an_4
Convertible Notes (Related and Unrelated Party) - Schedule of Fair Value Assumptions Used (Details) | 6 Months Ended |
Jun. 30, 2020 | |
L and P Warrants [Member] | Expected Life [Member] | Minimum [Member] | |
Fair value assumptions, measurement input, term | 1 year |
L and P Warrants [Member] | Expected Life [Member] | Maximum [Member] | |
Fair value assumptions, measurement input, term | 3 years |
L and P Warrants [Member] | Volatility [Member] | Minimum [Member] | |
Fair value assumptions, measurement input, percentage | 7674.00% |
L and P Warrants [Member] | Volatility [Member] | Maximum [Member] | |
Fair value assumptions, measurement input, percentage | 9800.00% |
L and P Warrants [Member] | Risk Free Interest Rate [Member] | Minimum [Member] | |
Fair value assumptions, measurement input, percentage | 15.00% |
L and P Warrants [Member] | Risk Free Interest Rate [Member] | Maximum [Member] | |
Fair value assumptions, measurement input, percentage | 41.00% |
L and P Warrants [Member] | Dividend Yield [Member] | |
Fair value assumptions, measurement input, percentage | 0.00% |
Warrant [Member] | Expected Life [Member] | |
Fair value assumptions, measurement input, term | 1 year 8 months 16 days |
Warrant [Member] | Volatility [Member] | |
Fair value assumptions, measurement input, percentage | 8802.00% |
Warrant [Member] | Risk Free Interest Rate [Member] | |
Fair value assumptions, measurement input, percentage | 37.00% |
Warrant [Member] | Dividend Yield [Member] | |
Fair value assumptions, measurement input, percentage | 0.00% |
Convertible Notes (Related an_5
Convertible Notes (Related and Unrelated Party) - Schedule of Convertible Notes (Details) - USD ($) | Jun. 30, 2020 | Dec. 31, 2019 |
Total convertible notes | $ 1,203,567 | $ 2,740,561 |
Convertible Note One[Member] | ||
Convertible notes | 1,181,167 | 2,704,800 |
Less: Debt discount (warrant value) | (92,266) | (325,747) |
Less: Debt discount (derivative value) (Note 8) | (638,988) | |
Less: Debt discount (issuance costs paid) | (6,004) | (27,000) |
Less: Note repayments/conversion | (110,166) | (803,634) |
Add: Debt discount amortization | 13,605 | 898,940 |
Total convertible notes | 986,336 | 1,808,371 |
Convertible Note Two [Member] | ||
Convertible notes | 235,200 | 1,363,200 |
Less: Debt discount (warrant value) | (1,817) | (212,763) |
Less: Debt discount (derivative value) (Note 8) | (13,528) | (697,186) |
Less: Debt discount (issuance costs paid) | (6,004) | (23,700) |
Add: Debt discount amortization | 3,380 | 508,639 |
Total convertible notes | $ 217,231 | $ 932,190 |
Convertible Notes (Related an_6
Convertible Notes (Related and Unrelated Party) - Schedule of Future Maturities of Convertible Notes (Details) | Jun. 30, 2020USD ($) |
Debt Disclosure [Abstract] | |
Years ending December 31, 2020 | $ 67,201 |
Years ending December 31, 2021 | 168,000 |
Years ending December 31, 2022 | 1,071,000 |
Years ending December 31, 2023 | |
Years ending December 31, 2023 | |
Future maturity of convertible notes, total | $ 1,306,201 |
Derivative Liabilities (Details
Derivative Liabilities (Details Narrative) - USD ($) | Mar. 20, 2020 | Jun. 30, 2020 |
Convertible noteholders description | The Convertible Noteholders discussed in Note 7 were provided the option of extending their notes by 24 months or 12 months for the Milestone I March 14, 2020 and Milestone II November 30, 2020 Convertible Note maturities, respectively. | |
Derivative liabilities | $ 34,143 | |
Series CN Convertible Notes 1 [Member] | ||
Offering for common stock and debt restructuring | $ 110,167 | |
Series CN Convertible Notes 2 [Member] | ||
Offering for common stock and debt restructuring | 168,000 | |
Debt discount related to derivative liabilities | $ 13,528 | |
Debt Conversion and Modified Extension Terms [Member] | ||
Derivative liabilities | $ 6,774 |
Derivative Liabilities - Schedu
Derivative Liabilities - Schedule of Fair Value of the Derivative Liability (Details) - Derivative Liabilities [Member] - Series CN Convertible Note 2 of 2 [Member] | 6 Months Ended | 12 Months Ended |
Jun. 30, 2020 | Dec. 31, 2019 | |
Expected Life [Member] | ||
Fair value assumptions, measurement input, term | 11 months 4 days | |
Expected Life [Member] | Minimum [Member] | ||
Fair value assumptions, measurement input, term | 5 months 1 day | |
Expected Life [Member] | Maximum [Member] | ||
Fair value assumptions, measurement input, term | 1 year 8 months 5 days | |
Volatility [Member] | ||
Fair value assumptions, measurement input, percentage | 104.89 | |
Volatility [Member] | Minimum [Member] | ||
Fair value assumptions, measurement input, percentage | 100.44 | |
Volatility [Member] | Maximum [Member] | ||
Fair value assumptions, measurement input, percentage | 133.12 | |
Risk Free Interest Rate [Member] | ||
Fair value assumptions, measurement input, percentage | 1.58 | |
Risk Free Interest Rate [Member] | Minimum [Member] | ||
Fair value assumptions, measurement input, percentage | 0.16 | |
Risk Free Interest Rate [Member] | Maximum [Member] | ||
Fair value assumptions, measurement input, percentage | 0.18 | |
Dividend Yield [Member] | ||
Fair value assumptions, measurement input, percentage | 0 | 0 |
Derivative Liabilities - Sche_2
Derivative Liabilities - Schedule of Derivative Liability Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Inputs, Level 3 [Member] | 6 Months Ended |
Jun. 30, 2020USD ($) | |
Derivative liabilities, beginning balance | $ 211,028 |
Extinguishment change in derivative from conversion | (23,100) |
Extinguishment change in derivative from extension | (3,440) |
Initial derivative value - March 20, 2020 | 13,528 |
Net gain from change in value | (157,099) |
Derivative liabilities, ending balance | $ 40,917 |
Derivative Liabilities - Sche_3
Derivative Liabilities - Schedule of Fair Value Hierarchy of Assets and Liabilities (Details) - USD ($) | Jun. 30, 2020 | Dec. 31, 2019 |
Derivative Liability | $ 40,917 | $ 211,028 |
Fair Value, Inputs, Level 1 [Member] | ||
Derivative Liability | ||
Fair Value, Inputs, Level 2 [Member] | ||
Derivative Liability | ||
Fair Value, Inputs, Level 3 [Member] | ||
Derivative Liability | $ 40,917 | $ 211,028 |
Commitments and Contingencies_2
Commitments and Contingencies (Details Narrative) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Dec. 31, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |||||
Operating lease expire date | Jun. 30, 2023 | ||||
Lease expense | $ 19,782 | $ 13,612 | $ 39,844 | $ 50,813 | |
Right use of asset | 176,325 | 176,325 | $ 203,287 | ||
Lease liability | $ 188,509 | $ 188,509 | |||
Lease discount rate | 10.00% | 10.00% | |||
Remaining lease term | 3 years | 3 years |
Commitments and Contingencies -
Commitments and Contingencies - Schedule of Estimate Future Maturities of Lease Liabilities (Details) | Jun. 30, 2020USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
2020 (six months remaining) | $ 38,152 |
2021 | 78,021 |
2022 | 80,361 |
2023 | 20,238 |
Total Lease payments | 216,772 |
Less: imputed interest | (28,263) |
Total lease liability | $ 188,509 |
Stockholders' Equity (Details N
Stockholders' Equity (Details Narrative) - USD ($) | Mar. 20, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 |
Class of Stock [Line Items] | ||||||
Exercise price of options ranged | $ 0.37 | $ 0.37 | ||||
Stock option vesting period | 3 years | |||||
Stock option exercisable term | 8 years | |||||
Fair value of stock options issued | $ 209,700 | |||||
Common stock trading price per share | $ 0.38 | $ 0.38 | ||||
Cancellation of options | 30,000 | |||||
Options expired | 625,423 | |||||
Fair value of warrants | $ 307,460 | |||||
Equity-based compensation included additional paid in capital | 55,812 | $ 134,607 | 194,524 | $ 271,548 | ||
Debt conversion, description | If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the "Six Month Price") exceeds or equals $0.50 per share (the "Target Price"), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $0.35 per share, in which case the Company shall issue to each investor, pro-rata based on such investor's investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for a number of shares of common stock equal to 50% of the difference between the number of shares issued to such investor at closing and the number of shares that would have been issued to such investor at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no eventless than $0.45 per share. The exercise price per share for each warrant will automatically adjust to the sum of $0.10 per share and the Six-Month Price, but in no event less than $0.45 per share | |||||
O Warrants [Member] | ||||||
Class of Stock [Line Items] | ||||||
Stock option exercisable term | 3 years | |||||
Common stock trading price per share | $ 0.50 | |||||
O Warrants [Member] | Minimum [Member] | ||||||
Class of Stock [Line Items] | ||||||
Warrant exercise price | $ 0.60 | |||||
Private Placement Offering [Member] | ||||||
Class of Stock [Line Items] | ||||||
Number of options to purchase common stock | 7,650,000 | |||||
Stock issued price per shares | $ 0.50 | |||||
Proceeds from private placement | $ 3,825,000 | |||||
Private placement description | The $3.825 million was received and collected in April 2020. | |||||
Executive Deferred Compensation [Member] | ||||||
Class of Stock [Line Items] | ||||||
Executive deferred compensation payments with the issuance of warrants | $ 1,573,988 | |||||
Fair value of warrants | $ 251,837 | |||||
Issuance of warrants | $ 167,892 | 167,892 | ||||
Stock based compensation | $ 83,945 | |||||
Employees [Member] | ||||||
Class of Stock [Line Items] | ||||||
Number of options to purchase common stock | 850,000 | |||||
Board Members [Member] | ||||||
Class of Stock [Line Items] | ||||||
Number of options to purchase common stock | 96,899 |
Stockholders' Equity - Summary
Stockholders' Equity - Summary of Fair Value of Options Using Black-Sholes Option Pricing Model (Details) | 6 Months Ended |
Jun. 30, 2020 | |
Volatility (based on a comparable company), minimum | 73.36% |
Volatility (based on a comparable company), maximum | 75.82% |
Risk Free interest rate. minimum | 0.30% |
Risk Free interest rate, maximum | 1.61% |
Dividend yield (on common stock) | 0.00% |
Minimum [Member] | |
Expected life (in years) | 5 years 6 months |
Maximum [Member] | |
Expected life (in years) | 8 years |
Stockholders' Equity - Summar_2
Stockholders' Equity - Summary of Outstanding Stock Options Issued to Employees and Directors (Details) | 6 Months Ended |
Jun. 30, 2020USD ($)$ / sharesshares | |
Number of Options, Cancelled/Expired | shares | (30,000) |
Exercise price per share, Outstanding, Ending | $ 0.37 |
Employees and Directors [Member] | |
Number of Options, Outstanding, Beginning | shares | 7,197,024 |
Number of Options, Issued | shares | 946,899 |
Number of Options, Cancelled/Expired | shares | (625,423) |
Number of Options, Outstanding, Ending | shares | 7,575,256 |
Number of Options, Exercisable | shares | 3,944,901 |
Exercise price per share, Issued | |
Average remaining term in years, Outstanding, Beginning | 4 years 6 months 18 days |
Average remaining term in years, Outstanding, Issued | 7 years 9 months 7 days |
Average remaining term in years, Outstanding, Ending | 4 years 4 months 17 days |
Average remaining term in years, Exercisable | 3 years 3 months 26 days |
Aggregate intrinsic value at date of grant, Outstanding, Beginning | $ | |
Aggregate intrinsic value at date of grant, Issued | $ | |
Aggregate intrinsic value at date of grant, Outstanding, Ending | $ | |
Aggregate intrinsic value at date of grant, Exercisable | $ | |
Employees and Directors [Member] | Minimum [Member] | |
Exercise price per share, Outstanding, Beginning | $ 0.40 |
Exercise price per share, Outstanding, Ending | 0.37 |
Exercise price per share, Exercisable | 0.40 |
Employees and Directors [Member] | Maximum [Member] | |
Exercise price per share, Outstanding, Beginning | 0.87 |
Exercise price per share, Issued | 0.37 |
Exercise price per share, Outstanding, Ending | 0.87 |
Exercise price per share, Exercisable | $ 0.87 |
Stockholders' Equity - Schedule
Stockholders' Equity - Schedule of Changes in Stockholders' Equity (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Balance | $ 283,724 | $ (35,048) | ||
Exercise of warrants | 1,884,872 | |||
Issuance of stock for services | 25,000 | 181,039 | ||
Equity based compensation | 194,524 | 271,548 | ||
Warrants issued to Management | 167,892 | 758,754 | ||
Issuance of stock for capital raise | 3,797,800 | 2,400,000 | ||
Warrant Modification | 307,460 | |||
Conversion of debt | 1,333,757 | |||
Interest paid in shares | 379,350 | |||
Warrant issued for note extension | 75,184 | |||
Net (loss) for the year | (1,179,520) | (573,916) | (1,922,586) | (3,421,178) |
Balance | 4,353,549 | 2,347,447 | 4,353,549 | 2,347,447 |
Common Stock [Member] | ||||
Balance | $ 130 | $ 123 | ||
Balance, shares | 130,341,737 | 122,770,960 | ||
Exercise of warrants | $ 3 | |||
Exercise of warrants, shares | 3,141,454 | |||
Issuance of stock for services | ||||
Issuance of stock for services, shares | 27,601 | 173,406 | ||
Equity based compensation | ||||
Warrants issued to Management | ||||
Issuance of stock for capital raise | $ 8 | $ 4 | ||
Issuance of stock for capital raise, shares | 7,650,000 | 4,000,000 | ||
Warrant Modification | ||||
Conversion of debt | $ 5 | |||
Conversion of debt, shares | 4,770,030 | |||
Interest paid in shares | ||||
Interest paid in shares, shares | 632,251 | |||
Restricted stock issuance shares | 121,527 | |||
Net (loss) for the year | ||||
Balance | $ 143 | $ 130 | $ 143 | $ 130 |
Balance, shares | 143,543,146 | 130,085,820 | 143,543,146 | 130,085,820 |
Additional Paid in Capital [Member] | ||||
Balance | $ 47,030,716 | $ 41,118,649 | ||
Exercise of warrants | 1,884,869 | |||
Issuance of stock for services | 25,000 | 181,039 | ||
Equity based compensation | 194,524 | 271,548 | ||
Warrants issued to Management | 167,892 | 758,754 | ||
Issuance of stock for capital raise | 3,797,792 | 2,399,996 | ||
Warrant Modification | 18,899 | 307,460 | ||
Conversion of debt | 1,333,757 | |||
Interest paid in shares | 379,350 | |||
Warrant issued for note extension | 75,184 | |||
Net (loss) for the year | ||||
Balance | $ 53,023,114 | $ 46,922,315 | 53,023,114 | 46,922,315 |
Accumulated (Deficit) [Member] | ||||
Balance | (46,747,122) | (41,153,820) | ||
Exercise of warrants | ||||
Issuance of stock for services | ||||
Equity based compensation | ||||
Warrants issued to Management | ||||
Issuance of stock for capital raise | ||||
Warrant Modification | ||||
Conversion of debt | ||||
Interest paid in shares | ||||
Warrant issued for note extension | ||||
Net (loss) for the year | (1,922,586) | (3,421,178) | ||
Balance | $ (48,669,708) | $ (44,574,998) | $ (48,669,708) | $ (44,574,998) |
Stockholders' Equity - Schedu_2
Stockholders' Equity - Schedule of Changes in Stockholders' Equity (Details) (Parenthetical) | Jun. 30, 2020USD ($) |
Equity [Abstract] | |
Offering costs | $ 27,200 |
Outstanding Warrants - Summary
Outstanding Warrants - Summary of Outstanding Warrants (Details) - Warrant [Member] | 6 Months Ended |
Jun. 30, 2020USD ($)$ / sharesshares | |
Convertible Note [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Warrants | shares | 3,006,501 |
Price per share | $ 0.70 |
Remaining term in years | 7 months 10 days |
Intrinsic value at date of grant | $ | |
Settlement of Deferred Compensation [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Warrants | shares | 3,169,599 |
Remaining term in years | 4 years 2 months 30 days |
Intrinsic value at date of grant | $ | |
Minimum [Member] | Settlement of Deferred Compensation [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Price per share | $ 0.27 |
Maximum [Member] | Settlement of Deferred Compensation [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Price per share | $ 0.70 |
Private Placements of Common Stock [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Warrants | shares | 19,048,606 |
Remaining term in years | 1 year 8 months 16 days |
Intrinsic value at date of grant | $ | |
Private Placements of Common Stock [Member] | Minimum [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Price per share | $ 0.53 |
Private Placements of Common Stock [Member] | Maximum [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Price per share | $ 1 |
Private Placement of Notes [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Warrants | shares | 1,355,000 |
Price per share | $ 1 |
Remaining term in years | 6 months |
Intrinsic value at date of grant | $ |
Income Taxes (Details Narrative
Income Taxes (Details Narrative) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Income Tax Disclosure [Abstract] | ||||
Estimated effective tax rate | $ 0 | |||
Interest and penalties tax positions | ||||
Unrecognized uncertain tax positions |
Liquidity (Details Narrative)
Liquidity (Details Narrative) - USD ($) | 6 Months Ended | |||
Jun. 30, 2020 | Jun. 30, 2019 | Dec. 31, 2019 | Dec. 31, 2018 | |
Net cash (used for) operating activities | $ (1,930,045) | $ (2,354,225) | ||
Purchase of property and equipment | 34,365 | 319,157 | ||
Sale of common stock | 3,825,000 | |||
Issuance of stock for capital raise | 3,797,800 | 2,400,000 | ||
Warrants exercised | 1,500,310 | |||
Debt maturity date | Mar. 31, 2022 | |||
Cash in escrow, and restricted cash and unrestricted | $ 3,398,276 | $ 2,268,315 | $ 1,091,374 | $ 1,041,569 |
Reducing general and administrative expenses, description | We have continued to significantly reduce core operating expenses, reducing total General and Administrative Expense in the first six months of 2020 by $1,480,799, or 39%, as compared with the first six months of 2019. | |||
Reducing general and administrative expenses | $ 1,480,799 | |||
Convertible Notes [Member] | ||||
Debt conversion converted amount | $ 2,374,763 |
Subsequent Events (Details Narr
Subsequent Events (Details Narrative) - Paycheck Protection Program [Member] - USD ($) | Jun. 05, 2020 | Jun. 30, 2020 |
Proceeds from loan | $ 568,000 | |
Extended the period of loan forgiveness, description | On June 5, 2020, the President signed a bill which extended the period of loan forgiveness for PPP loans from 8 to 24 weeks, which we believe will enable the loan to be completely forgiven. |